Product Information
IVABRADINE HCL 5 MG TABLET is a generic product labeled by Novadoz Pharmaceuticals LLC, priced at $0.7645 per EA under NDC 72205033660. Its NADAC has been published 38 times since Dec 3, 2025.
FDA first approved this application on Apr 28, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Novadoz Pharmaceuticals LLCNDC
72205033660
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
IVABRADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213483FDA Approved
4/28/2025
TE Code
AB
On Market Since
4/28/2025
Pharmacological Classes
Price Statistics
The NADAC for IVABRADINE HCL 5 MG TABLET has been published 38 times since Dec 3, 2025, and over the history we have for it it has declined 73.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7645 per EA |
|---|---|
| All-time high | $2.8731 (Dec 10, 2025) |
| All-time low | $0.7645 (Aug 19, 2026) |
| 52-week high | $2.8731 |
| 52-week low | $0.7645 |
| Median price | $0.8436 |
| Average price | $1.1933 |
| Largest weekly change | -40.9% (Feb 18, 2026) |
| Weeks tracked | 38 |
| Tracking since | Dec 3, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of IVABRADINE HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IVABRADINE HCL 5 MG TABLET, manufactured by Novadoz Pharmaceuticals LLC, is $0.7645 per EA (NDC 72205033660), effective Aug 19, 2026.
How has the price of IVABRADINE HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for IVABRADINE HCL 5 MG TABLET has declined 73.4%. It has been tracked across 38 weekly CMS publications since Dec 3, 2025.
What are the highest and lowest recorded NADAC prices for IVABRADINE HCL 5 MG TABLET?
Since Dec 3, 2025, the NADAC for IVABRADINE HCL 5 MG TABLET has ranged from a low of $0.7645 (Aug 19, 2026) to a high of $2.8731 (Dec 10, 2025), with a median of $0.8436 per EA.
Are there cheaper alternatives to IVABRADINE HCL 5 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as IVABRADINE HCL 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures IVABRADINE HCL 5 MG TABLET?
IVABRADINE HCL 5 MG TABLET (NDC 72205033660) is labeled by Novadoz Pharmaceuticals LLC, and CMS classifies it as a generic product.